| Name | DY 268 |
|---|---|
| Synonyms |
DY 268
1H-Pyrazole-4-carboxamide, 1-[(3-methoxyphenyl)methyl]-N-[4-methyl-3-(4-morpholinylsulfonyl)phenyl]-3-(4-methylphenyl)- 1-(3-Methoxybenzyl)-N-[4-methyl-3-(4-morpholinylsulfonyl)phenyl]-3-(4-methylphenyl)-1H-pyrazole-4-carboxamide |
| Description | DY268 is a farnesoid X receptor (FXR) antagonist (IC50=7.5 nM in a time-resolved FRET assay). It inhibits FXR transactivation in a cell-based assay with an IC50 value of 468 nM[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C30H32N4O5S |
| Molecular Weight | 560.664 |
| Exact Mass | 560.209351 |
| LogP | 3.65 |
| Index of Refraction | 1.638 |
| Storage condition | -20°C |